Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells

Non-small cell lung cancer (NSCLC) is the most deadly type of cancer worldwide. Although a number of therapies are used in NSCLC treatment, their therapeutic efficacy remains low. Lenalidomide was originally approved for use in patients with myelodysplastic syndromes, which are associated with 5q de...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: KIM, KARAM, AN, SUNGKWAN, CHA, HWA JUN, CHOI, YEONG MIN, CHOI, SUNG JIN, AN, IN-SOOK, LEE, HONG GHI, MIN, YOO HONG, LEE, SU-JAE, BAE, SEUNGHEE
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2013
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573063/
https://ncbi.nlm.nih.gov/pubmed/23420263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.1054
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items